Blogs
on December 7, 2022
The global avian influenza vaccines market size was valued at USD 140.0 million in 2021 and is poised to grow at a CAGR of 4.2% over 2022-2028. Avian influenza is an infectious disease caused by the bird flu Type-A virus. Aquatic birds are the virus's most common vector. The avian influenza type A virus can be categorized as neuraminidase (NA) or hemagglutinin (HA) based on protein remains on the virus surface (HA). It is divided into two categories based on molecular characteristics: highly pathogenic and low pathogenic. If the virus penetrates the eyes, nose, or mouth, it can cause serious illness in people. For the prevention and treatment of infection, the antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza) are included in the Avian Influenza Vaccines. Ducks, chickens, geese, and other birds regularly consume it.
View detailed report description here https://precisionbusinessinsights.com/market-reports/avian-influenza-vaccines-market/
Diseases are becoming more prevalent, especially in developing countries, and are a primary cause of over 95% of poultry death rates. The global avian influenza vaccines market is fueled by rising demand for poultry for human consumption, ongoing research for the development of effective disease-prevention vaccinations, and a growing number of outbreaks. However, the vaccinations' quick degradation at room temperature within a few hours makes them unsuitable for shipment to remote areas. Furthermore, according to the United States Department of Agriculture (USDA), existing vaccinations do not meet the required levels of efficacy and should not be utilized to treat avian influenza outbreaks. During the projected period, these factors are anticipated to hinder the avian influenza vaccines market. Furthermore, a lack of understanding about the disease among poultry keepers is expected to stymie the market for avian influenza vaccines in the coming years.
The global avian influenza vaccines market segmentation:
1) By Strain Type: Type H9, Type H7, Type H5 and Others.
2) By Vaccine Type: Live Recombinant Vaccines, Inactivated Vaccines and Combination Vaccines.
3) By Application Type: Duck & Goose, Chicken and Others.
APAC has the potential to outperform the global Avian Influenza Vaccines Market. In the APAC region, increased avian influenza epidemics are to blame for the market's rise. Many government steps have been implemented to meet the emerging issue, following the swift installation of proper management systems for avian influenza vaccine development. The Avian Influenza Vaccines Market in Europe is estimated to account for the second-largest share of the global market during the projected period.
Request sample report https://precisionbusinessinsights.com/request-sample?product_id=37365
The major players working in avian influenza vaccines market, which include CEVA, FATRO, Biken, HVRI, Merial, Merck, Zoetis, Elanco, Avimex Laboratories
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Posted in: Health
Topics:
avian influenza vaccines market